🪙 Altcoins: Injective News
Injective (INJ) has made significant strides in recent developments. According to CoinGecko, Injective's on-chain finance ecosystem is expected to converge by 2026. Meanwhile, Crypto Briefing reported that Injective has become the first MEV-resistant Layer 1 (L1) blockchain to go live on mainnet, enhancing its security and fairness.
The MEV-resistance feature is a notable upgrade, as it mitigates the risk of malicious actors exploiting transaction ordering. This development could attract more users and investors to the Injective ecosystem. Additionally, Injective concluded its July INJ Community BuyBack on July 8th, as reported by TradingView, which may help maintain a stable token supply.
These advancements have likely contributed to a positive sentiment around INJ. As of now, INJ is trading at $25.42, up 10.5% over the past week. With its innovative features and growing adoption, Injective may continue to gain traction in the altcoin market.
The MEV-resistance feature is a notable upgrade, as it mitigates the risk of malicious actors exploiting transaction ordering. This development could attract more users and investors to the Injective ecosystem. Additionally, Injective concluded its July INJ Community BuyBack on July 8th, as reported by TradingView, which may help maintain a stable token supply.
These advancements have likely contributed to a positive sentiment around INJ. As of now, INJ is trading at $25.42, up 10.5% over the past week. With its innovative features and growing adoption, Injective may continue to gain traction in the altcoin market.